DZ2510A1 - Composition comprenant de la 5-Ä4-Ä2-(n-méthyl-n-(2-pyridyl)amino)éthoxyÜbenzylÜthiazolidine-2,4-dione et procédé pour sa préparation. - Google Patents

Composition comprenant de la 5-Ä4-Ä2-(n-méthyl-n-(2-pyridyl)amino)éthoxyÜbenzylÜthiazolidine-2,4-dione et procédé pour sa préparation.

Info

Publication number: DZ2510A1
Authority: DZ; Algeria
Prior art keywords: ethoxyübenzylüthiazolidine; dione; pyridyl; amino; methyl
Prior art date: 1997-06-05

Application number

DZ980120A

Other languages

English (en)

Inventor

Jai Patel

Hamish Ross

Jeffrey Roger Granett

Robin Price

Nigel Wray

Original Assignee

Smithkline Beecham Corp

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-05

Filing date

1998-06-03

Publication date

2003-01-25

1997-06-18 Priority claimed from GBGB9712851.6A external-priority patent/GB9712851D0/en

1998-06-03 Application filed by Smithkline Beecham Corp, Smithkline Beecham Plc filed Critical Smithkline Beecham Corp

2003-01-25 Application granted granted Critical

2003-01-25 Publication of DZ2510A1 publication Critical patent/DZ2510A1/fr

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Diabetes (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Hematology (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Obesity (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)

DZ980120A 1997-06-05 1998-06-03 Composition comprenant de la 5-Ä4-Ä2-(n-méthyl-n-(2-pyridyl)amino)éthoxyÜbenzylÜthiazolidine-2,4-dione et procédé pour sa préparation. DZ2510A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9711683.4A GB9711683D0 (en)	1997-06-05	1997-06-05	Composition
GBGB9712851.6A GB9712851D0 (en)	1997-06-18	1997-06-18	Composition

Publications (1)

Publication Number	Publication Date
DZ2510A1 true DZ2510A1 (fr)	2003-01-25

Family

ID=26311662

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ980120A DZ2510A1 (fr)	1997-06-05	1998-06-03	Composition comprenant de la 5-Ä4-Ä2-(n-méthyl-n-(2-pyridyl)amino)éthoxyÜbenzylÜthiazolidine-2,4-dione et procédé pour sa préparation.

Country Status (29)

Country	Link
EP (1)	EP0998284A1 (fr)
JP (1)	JP2001521553A (fr)
KR (1)	KR20010013410A (fr)
CN (3)	CN1112926C (fr)
AP (1)	AP1214A (fr)
AR (2)	AR015120A1 (fr)
AU (1)	AU8215098A (fr)
BG (1)	BG104048A (fr)
BR (1)	BR9810405A (fr)
CA (2)	CA2292629C (fr)
CO (1)	CO4940400A1 (fr)
DZ (1)	DZ2510A1 (fr)
EA (1)	EA002384B1 (fr)
GB (1)	GB9711683D0 (fr)
HU (1)	HUP0004070A3 (fr)
ID (1)	ID24264A (fr)
IL (1)	IL133074A0 (fr)
MX (1)	MXPA99011322A (fr)
NO (2)	NO995938L (fr)
NZ (2)	NZ523725A (fr)
OA (1)	OA11306A (fr)
PE (1)	PE78899A1 (fr)
PL (1)	PL337201A1 (fr)
SK (1)	SK164899A3 (fr)
TR (2)	TR200002790T2 (fr)
TW (1)	TW570797B (fr)
UY (1)	UY25032A1 (fr)
WO (1)	WO1998055122A1 (fr)
ZA (2)	ZA9811572B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7045519B2 (en)	1998-06-19	2006-05-16	Chiron Corporation	Inhibitors of glycogen synthase kinase 3
PL351684A1 (en) *	1999-04-23	2003-06-02	Smithkline Beecham Plc	Polymorph of 5−[4−[2− (n−methyl−n−( 2−pyridyl)amino) ethoxy]benzyl] thiazolidine−2,4−dione, maleic acid salt
US20040248945A1 (en)	1999-04-23	2004-12-09	Smithkline Beecham P.L.C.	Thiazolidinedione derivative and its use as antidiabetic
AU765498B2 (en)	1999-04-23	2003-09-18	Smithkline Beecham Plc	Novel pharmaceutical
GB0021978D0 (en)	2000-09-07	2000-10-25	Smithkline Beecham Plc	Novel pharmaceutical
GB0127805D0 (en) *	2001-11-20	2002-01-09	Smithkline Beecham Plc	Pharmaceutical composition
GB0129871D0 (en) *	2001-12-13	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
AU2002350965A1 (en) *	2001-12-13	2003-06-23	Smithkline Beecham Plc	Toluenesulfonate hydrates of a thiazolidinedione derivative
GB0129876D0 (en) *	2001-12-13	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
GB0130509D0 (en) *	2001-12-20	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
ES2294980T1 (es) *	2006-05-09	2008-04-16	Teva Pharmaceutical Industries Ltd.	Acido 2-n-(5-((4-(2-(metil-2-piridinilamino)etoxi)fenil)metil)-2,4-tiazolidindiona)-butanodioico, procedimientos de preparacion y composiciones con maleato de rosiglitazona.
US7435741B2 (en)	2006-05-09	2008-10-14	Teva Pharmaceutical Industries, Ltd.	2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
WO2015008234A1 (fr) *	2013-07-17	2015-01-22	Glenmark Pharmaceuticals S.A.	Composés hétécycliques bicycliques utilisés en tant que modulateurs des ror-gamma

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE186724T1 (de) *	1987-09-04	1999-12-15	Beecham Group Plc	Substituierte thiazolidindionderivate
GB9218830D0 (en) *	1992-09-05	1992-10-21	Smithkline Beecham Plc	Novel compounds
JPH09512249A (ja) *	1994-02-10	1997-12-09	スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー	腎臓疾患を治療するためのインスリンセンシタイザーの使用
CN1192683A (zh) *	1995-08-10	1998-09-09	沃尼尔·朗伯公司	减少非胰岛素依赖型糖尿病患者外源性胰岛素给药量的方法
WO1997018811A1 (fr) *	1995-11-17	1997-05-29	Warner-Lambert Company	Procede de traitement de dystrophie myotonique
IL120443A (en) *	1996-03-18	2000-07-16	Sankyo Co	Use of an insulin sensitizer for the manufacture of a medicament for the treatment or prophylaxis of pancreatitis
PL331148A1 (en) *	1996-07-12	1999-06-21	Smithkline Beecham Plc	Novel method of treating the leptin immunity

1997
- 1997-06-05 GB GBGB9711683.4A patent/GB9711683D0/en active Pending
1998
- 1998-06-02 ID IDW991520A patent/ID24264A/id unknown
- 1998-06-02 IL IL13307498A patent/IL133074A0/xx unknown
- 1998-06-02 JP JP50158799A patent/JP2001521553A/ja not_active Ceased
- 1998-06-02 TR TR2000/02790T patent/TR200002790T2/xx unknown
- 1998-06-02 AU AU82150/98A patent/AU8215098A/en not_active Abandoned
- 1998-06-02 WO PCT/EP1998/003478 patent/WO1998055122A1/fr not_active Ceased
- 1998-06-02 CN CN98805686A patent/CN1112926C/zh not_active Expired - Lifetime
- 1998-06-02 TR TR1999/02963T patent/TR199902963T2/xx unknown
- 1998-06-02 NZ NZ523725A patent/NZ523725A/en unknown
- 1998-06-02 MX MXPA99011322A patent/MXPA99011322A/es unknown
- 1998-06-02 KR KR19997011411A patent/KR20010013410A/fr not_active Ceased
- 1998-06-02 EP EP98932144A patent/EP0998284A1/fr not_active Withdrawn
- 1998-06-02 BR BR9810405-5A patent/BR9810405A/pt not_active IP Right Cessation
- 1998-06-02 CN CNA2003101199090A patent/CN1526391A/zh active Pending
- 1998-06-02 CA CA002292629A patent/CA2292629C/fr not_active Expired - Fee Related
- 1998-06-02 HU HU0004070A patent/HUP0004070A3/hu unknown
- 1998-06-02 AP APAP/P/1999/001696A patent/AP1214A/en active
- 1998-06-02 CA CA002333352A patent/CA2333352A1/fr not_active Abandoned
- 1998-06-02 PL PL98337201A patent/PL337201A1/xx unknown
- 1998-06-02 SK SK1648-99A patent/SK164899A3/sk unknown
- 1998-06-02 EA EA199901116A patent/EA002384B1/ru not_active IP Right Cessation
- 1998-06-03 DZ DZ980120A patent/DZ2510A1/fr active
- 1998-06-04 AR ARP980102650A patent/AR015120A1/es not_active Application Discontinuation
- 1998-06-04 ZA ZA9811572A patent/ZA9811572B/xx unknown
- 1998-06-04 AR ARP980102649A patent/AR008198A1/es not_active Application Discontinuation
- 1998-06-04 UY UY25032A patent/UY25032A1/es not_active IP Right Cessation
- 1998-06-04 ZA ZA9804826A patent/ZA984826B/xx unknown
- 1998-06-04 CO CO98031614A patent/CO4940400A1/es unknown
- 1998-06-05 PE PE1998000466A patent/PE78899A1/es not_active Application Discontinuation
- 1998-10-23 TW TW087117536A patent/TW570797B/zh not_active IP Right Cessation
1999
- 1999-12-02 OA OA9900267A patent/OA11306A/en unknown
- 1999-12-03 NO NO995938A patent/NO995938L/no not_active Application Discontinuation
- 1999-12-27 BG BG104048A patent/BG104048A/bg unknown
2001
- 2001-09-03 NZ NZ513922A patent/NZ513922A/xx unknown
2002
- 2002-11-05 CN CN02149972A patent/CN1430959A/zh active Pending
2004
- 2004-02-20 NO NO20040738A patent/NO20040738L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CO4940400A1 (es)	2000-07-24
TW570797B (en)	2004-01-11
AR008198A1 (es)	1999-12-29
AP9901696A0 (en)	1999-12-31
TR199902963T2 (xx)	2000-02-21
KR20010013410A (fr)	2001-02-26
NZ513922A (en)	2001-09-28
CN1112926C (zh)	2003-07-02
CN1526391A (zh)	2004-09-08
GB9711683D0 (en)	1997-08-06
CA2292629C (fr)	2004-01-06
ZA984826B (en)	1999-08-03
WO1998055122A1 (fr)	1998-12-10
CA2292629A1 (fr)	1998-12-10
NO995938L (no)	2000-02-02
SK164899A3 (en)	2000-11-07
NO995938D0 (no)	1999-12-03
BG104048A (bg)	2000-07-31
HUP0004070A3 (en)	2002-03-28
CA2333352A1 (fr)	1998-12-10
TR200002790T2 (tr)	2001-11-21
MXPA99011322A (es)	2004-12-02
NZ523725A (en)	2004-09-24
BR9810405A (pt)	2000-08-29
ZA9811572B (en)	1999-07-22
CN1430959A (zh)	2003-07-23
EP0998284A1 (fr)	2000-05-10
ID24264A (id)	2000-07-13
AU8215098A (en)	1998-12-21
PE78899A1 (es)	1999-10-22
NO20040738L (no)	2000-02-02
OA11306A (en)	2003-10-22
IL133074A0 (en)	2001-03-19
PL337201A1 (en)	2000-08-14
AR015120A1 (es)	2001-04-18
CN1259050A (zh)	2000-07-05
JP2001521553A (ja)	2001-11-06
HUP0004070A2 (hu)	2002-02-28
AP1214A (en)	2003-10-08
EA199901116A1 (ru)	2000-06-26
UY25032A1 (es)	1998-11-26
EA002384B1 (ru)	2002-04-25

Similar Documents

Publication	Publication Date	Title
HUP0001539A3 (en)	2003-01-28	2-(1-iminoethylamino)ethyl-homocysteine, process for its preparation and pharmaceutical compositions containing the same
DZ2457A1 (fr)	2004-11-08	Derivés de nicotinamide nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
HUP0004024A3 (en)	2001-10-29	Azabenzimidazole-based compounds, process for their preparation and pharmaceutical composition thereof
EE05214B1 (et)	2009-10-15	Polool-IFN- β konjugaat, selle valmistamismeetod ja farmatseutiline kompositsioon
EE05232B1 (et)	2009-12-15	Reguleeritud vabastamisega graanul, meetod selle valmistamiseks ning seda sisaldav mitmehikuline ravimvorm
DZ2172A1 (fr)	2002-12-01	Dérivés de triazole utiles on thérapeutique, procédé pour leur préparation et compositions les contenant.
IL135920A0 (en)	2001-05-20	2-aryl -8-oxodihydropurine derivative, process for the preparation thereof, pharmaceutical composition containing the same and intermediate therefor
AU7640696A (en)	1997-07-03	Thiazolidinedione derivatives, method for preparing the derivatives and pharmaceutical compositions containing same
CY2369B1 (en)	2004-06-04	Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same.
BR9810654B8 (pt)	2013-02-19	mÉtodo de preparaÇço de um polipeptÍdeo, molÉculas de anticorpo e composiÇço.
ZA9811759B (en)	1999-07-28	Novel indole derivatives, processes for their preparation, their use and pharmaceutical compositions containing them.
DZ2197A1 (fr)	2002-12-02	Dérivés de 6-phénylpyridyl-2-amine, procédé pour leur préparation et compositions pharmaceutiques les contenant.
HUP0100243A3 (en)	2001-09-28	Insoluble compositions comprising insuline and/or insuline-analogs and their derivatives, process for preparation thereof and their use for controlling blood glucose
HUP9801357A3 (en)	2000-11-28	Imidazoline-, imidazole-, oxazoline and thiazoline derivatives, pharmaceutical compositions containing them and process for producing them
DZ2114A1 (fr)	2002-07-22	Procédé pour la préparation du d-tartrate de (-)-cis-6(s)-phényl-5}4-(2-pyrrolidine-1-ylethoxy)-phénylÜ-5,6,7,8-tétrahydronaphtalène-2-ol.
DZ2074A1 (fr)	2002-07-22	Formulation nouvelle contenant de la paroxétine, et procédé pour sa préparation.
DZ3079A1 (fr)	2004-10-24	Procédé pour la préparation de 4-carboxy-amino-2-substitué-1,2,3,4 tétrahydroquinolé.
ZA974984B (en)	1997-12-30	New substituted thiazolidine-2,4-dione derivatives, processes for the obtaining thereof, and pharmaceutical compositions containing them.
ZA985406B (en)	1999-12-22	Pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical preparations containing these compounds.
IL136425A0 (en)	2001-06-14	Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use
DZ2188A1 (fr)	2002-12-02	Dérivés de quinoxalinedone, procédés et intermédiaires pour leur préparation et compositions pharmaceutiques les contenant.
FR2791059B1 (fr)	2005-04-01	Proteine modifiee, procede de preparation de celle-ci et compositions pour une application externe contenant la proteine modifiee
DK0838469T3 (da)	2002-03-18	10,13,15-trioxatricyclo(9.2.1 9.6)-pentadecanon-derivater, fremgangsmåde til deres fremstilling og lægemidler indeholdende disse forbindelser
CU22890A3 (es)	2004-01-23	Nuevo proceso de preparacion de derivados de fenilimidazolidina.
HUP0001093A3 (en)	2001-07-30	Oxazolidines as 5-ht2a-antagonists, pharmaceutical compositions containing the same and process for their preparation